The hyperactivation of NF-κB has been proven in numerous age-associated diseases, such as atherosclerosis, diabetes, neurodegeneration or immunosenescence (Le Saux, Weyand & Goronzy, 2012; Tak & Firestein, 2001). This evidence concerns the gene NFKB1 and diabetes mellitus.